Explore how whole exome sequencing works, how capture design determines what is actually covered, and when whole genome sequencing is the better choice.
An overview of where next-generation sequencing is used, from whole-genome variant discovery to clinical liquid biopsy and single-cell transcriptomics.
The global epigenetics market is projected to grow from USD 2.22 billion in 2026 to USD 3.92 billion by 2031, registering a 12.0% CAGR. Growth is driven by oncology research, precision medicine, drug ...
It's been a super busy morning for Ingram Micro here already. We actually got to ring the opening bell, which happened right here this morning. So a great honor after going public in 2024 and getting ...
AI, combined with genomics, biotechnology and synthetic biology, is beginning not merely to read biology, but to understand, ...
Laurent Lévy, CEO of Nanobiotics, lays out a stark math problem at the heart of modern biotech: when you inject a cell therapy, oncolytic virus, ...
Explore how targeted RNA sequencing resolves hereditary cancer VUS, clarifies splicing effects, and strengthens pathogenic ...
New proprietary AI product turns a brand's design system into machine-readable code, so agents can apply brand correctly ...
In cancer, tumor escape often arises following treatments. This is especially true during deprivation therapies, where this phenomenon has been linked to steroid signaling reactivation despite ...
the Group as at 30 June 2026 can be represented as follows: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results